Legal Blog: The Lyon Firm Offers Legal News in Ohio and Nationwide

ohio sports injury lawsuits ohio sports injury lawsuits ohio sports injury lawsuits ohio sports injury lawsuits ohio sports injury lawsuits ohio sports injury lawsuits

Sports Injury: NCAA Concussion Lawsuit Consolidated

Written by Joseph Lyon on January 9, 2014. Posted in Personal Injury.

Brain Injury Lawyer reviewing Ohio Sports Injury Lawsuits as more and more athletes suffer serious head and neck injuries like concussions and CTE Ohio Sports injury lawsuits are becoming more and more common. Defective helmets do nothing to alleviate...

medtronic guidewires medtronic guidewires medtronic guidewires medtronic guidewires medtronic guidewires medtronic guidewires

Medtronic Recall

Written by Joseph Lyon on November 18, 2013. Posted in Medical Device Litigation.

Cincinnati, Ohio Medical Device Lawyer reviewing Defective Guidewires and Medtronic Recall Lawsuits Medtronic, Inc. announced today that the U.S. Food and Drug Administration has classified the company’s recently initiated voluntary field action...

defective guidewire recall defective guidewire recall defective guidewire recall defective guidewire recall defective guidewire recall defective guidewire recall

Guidewire Recall & Defective Guidewire: Coating May Delaminate And Detach

Written by Joseph Lyon on November 18, 2013. Posted in Medical Device Litigation.

Ohio Medical Device Lawyer reviewing Defective Guidewire Recall Issued due to reported injuries and complications “Medtronic, Inc. announced that FDA has classified the company’s recently initiated voluntary field action related to certain...

potiga vision loss levaquin lawyer potiga vision loss levaquin lawyer potiga vision loss levaquin lawyer potiga vision loss levaquin lawyer potiga vision loss levaquin lawyer potiga vision loss levaquin lawyer

FDA APPROVES LABEL CHANGES FOR POTIGA AND VISION LOSS

Written by Joseph Lyon on November 15, 2013. Posted in Pharmaceutical Litigation.

Ohio Pharmaceutical Lawyer: Potiga Vision Loss “On October 31, 2013, the FDA issued a drug safety communication informing the public that the Agency has approved changes to the drug label of the anti-seizure drug Potiga (active ingredient ezogabine),...

Sports Injury: NCAA Concussion Lawsuit Consolidated

Medtronic Recall

Guidewire Recall & Defective Guidewire: Coating May Delaminate And Detach

FDA APPROVES LABEL CHANGES FOR POTIGA AND VISION LOSS

About Us

Contact